Notalgia paresthetica: treatment review and algorithmic approach
Background: Notalgia paresthetica (NP) is a sensory neuropathy of the back characterized by a well demarcated, hyperpigmented macule or patch located medial or inferior to the scapulae. Symptoms include localized pruritus and pain, and the clinical course consists of remissions and relapses. It can...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-05-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2019.1603360 |
_version_ | 1797683673665896448 |
---|---|
author | Ahmed Ansari David Weinstein Naveed Sami |
author_facet | Ahmed Ansari David Weinstein Naveed Sami |
author_sort | Ahmed Ansari |
collection | DOAJ |
description | Background: Notalgia paresthetica (NP) is a sensory neuropathy of the back characterized by a well demarcated, hyperpigmented macule or patch located medial or inferior to the scapulae. Symptoms include localized pruritus and pain, and the clinical course consists of remissions and relapses. It can be an underrecognized and difficult disease to treat since conventional treatments for pruritus in inflammatory dermatosis have variable efficacy. There are a variety of treatment modalities, but strong evidence to suggest the superiority of any one treatment is lacking. Objective: This review describes the treatments that have been used for NP in the literature and evaluates their level of evidence with respect to their efficacy. We also present a treatment algorithm based on our analysis. Materials and methods: MEDLINE search was performed using the terms ‘notalgia,’ ‘paresthetica,’ and ‘treatment.’ All resulting articles have been included in this review. Results: Treatment options include topical agents (capsaicin, tacrolimus, anesthetic cream, and amitriptyline/ketamine), systemic agents (gabapentin, oxcarbazepine, and amitriptyline), procedural modalities (botulinum toxin A and narrowband UVB), and physical therapy. Conclusions: Treatment should begin with topical agents or physical therapy, then systemic agents, and finally procedural modalities. We recommend combining treatment options with physical therapy for sustained treatment response. |
first_indexed | 2024-03-12T00:18:34Z |
format | Article |
id | doaj.art-e25b81140a6d48b289e0ca6599e89dfc |
institution | Directory Open Access Journal |
issn | 0954-6634 1471-1753 |
language | English |
last_indexed | 2024-03-12T00:18:34Z |
publishDate | 2020-05-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Journal of Dermatological Treatment |
spelling | doaj.art-e25b81140a6d48b289e0ca6599e89dfc2023-09-15T14:08:35ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532020-05-0131442443210.1080/09546634.2019.16033601603360Notalgia paresthetica: treatment review and algorithmic approachAhmed Ansari0David Weinstein1Naveed Sami2University of Central FloridaUniversity of Central FloridaUniversity of Central FloridaBackground: Notalgia paresthetica (NP) is a sensory neuropathy of the back characterized by a well demarcated, hyperpigmented macule or patch located medial or inferior to the scapulae. Symptoms include localized pruritus and pain, and the clinical course consists of remissions and relapses. It can be an underrecognized and difficult disease to treat since conventional treatments for pruritus in inflammatory dermatosis have variable efficacy. There are a variety of treatment modalities, but strong evidence to suggest the superiority of any one treatment is lacking. Objective: This review describes the treatments that have been used for NP in the literature and evaluates their level of evidence with respect to their efficacy. We also present a treatment algorithm based on our analysis. Materials and methods: MEDLINE search was performed using the terms ‘notalgia,’ ‘paresthetica,’ and ‘treatment.’ All resulting articles have been included in this review. Results: Treatment options include topical agents (capsaicin, tacrolimus, anesthetic cream, and amitriptyline/ketamine), systemic agents (gabapentin, oxcarbazepine, and amitriptyline), procedural modalities (botulinum toxin A and narrowband UVB), and physical therapy. Conclusions: Treatment should begin with topical agents or physical therapy, then systemic agents, and finally procedural modalities. We recommend combining treatment options with physical therapy for sustained treatment response.http://dx.doi.org/10.1080/09546634.2019.1603360notalgia parestheticatreatmentreview |
spellingShingle | Ahmed Ansari David Weinstein Naveed Sami Notalgia paresthetica: treatment review and algorithmic approach Journal of Dermatological Treatment notalgia paresthetica treatment review |
title | Notalgia paresthetica: treatment review and algorithmic approach |
title_full | Notalgia paresthetica: treatment review and algorithmic approach |
title_fullStr | Notalgia paresthetica: treatment review and algorithmic approach |
title_full_unstemmed | Notalgia paresthetica: treatment review and algorithmic approach |
title_short | Notalgia paresthetica: treatment review and algorithmic approach |
title_sort | notalgia paresthetica treatment review and algorithmic approach |
topic | notalgia paresthetica treatment review |
url | http://dx.doi.org/10.1080/09546634.2019.1603360 |
work_keys_str_mv | AT ahmedansari notalgiaparestheticatreatmentreviewandalgorithmicapproach AT davidweinstein notalgiaparestheticatreatmentreviewandalgorithmicapproach AT naveedsami notalgiaparestheticatreatmentreviewandalgorithmicapproach |